|
Sign In to gain access to subscriptions and/or personal tools.
|
Managing Epilepsy in Tuberous Sclerosis Complex
Elizabeth Anne Thiele, MD, PhD
Department of Neurology, Harvard Medical School, and the Pediatric Epilepsy Program, Massachusetts General Hospital, Boston, MA, ethiele{at}partners.org
Epilepsy is very common in tuberous sclerosis complex and occurs in 80 to 90% of affected individuals during their lifetime. Onset usually occurs during childhood, and up to one third of children with tuberous sclerosis complex will develop infantile spasms. Although not completely understood, the incidence of epilepsy is thought to relate to the neuropathologic features of the disorder, including cortical tubers and other dysgenetic features. Individuals with tuberous sclerosis complex frequently have epileptiform features to their electroencephalograms. Treatment of epilepsy in tuberous sclerosis complex is similar to epilepsy resulting from other causes and includes anticonvulsant medications, the vagus nerve stimulator, and the ketogenic diet. Vigabatrin has been shown to be particularly effective in treating infantile spasms in the setting of tuberous sclerosis complex. Epilepsy surgery has a very important role in the management of children and adults with pharmacoresistant epilepsy in tuberous sclerosis complex. (J Child Neurol 2004;19:680686).
Journal of Child Neurology, Vol. 19, No. 9,
680-686 (2004)
DOI: 10.1177/08830738040190090801

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. W. Way, J. McKenna III, U. Mietzsch, R. M. Reith, H. C.-j. Wu, and M. J. Gambello
Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse
Hum. Mol. Genet.,
April 1, 2009;
18(7):
1252 - 1265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Chu-Shore, P. Major, M. Montenegro, and E. Thiele
Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex
Neurology,
March 31, 2009;
72(13):
1165 - 1169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Dworakowska and A. B Grossman
Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review
Endocr. Relat. Cancer,
March 1, 2009;
16(1):
45 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Nass and P. B. Crino
Tuberous sclerosis complex: A tale of two genes
Neurology,
March 18, 2008;
70(12):
904 - 905.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Meikle, D. M. Talos, H. Onda, K. Pollizzi, A. Rotenberg, M. Sahin, F. E. Jensen, and D. J. Kwiatkowski
A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival
J. Neurosci.,
May 23, 2007;
27(21):
5546 - 5558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Crino, K. L. Nathanson, and E. P. Henske
The Tuberous Sclerosis Complex.
N. Engl. J. Med.,
September 28, 2006;
355(13):
1345 - 1356.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Prather and P. J. de Vries
Behavioral and Cognitive Aspects of Tuberous Sclerosis Complex
J Child Neurol,
September 1, 2004;
19(9):
666 - 674.
[Abstract]
[PDF]
|
 |
|
|
|